Deferred radiotherapy and upfront procarbazine&ndash;ACNU&ndash;vincristine administration for 1p19q codeleted oligodendroglial tumors are associated  with favorable outcome without compromising patient performance, regardless of WHO grade

Original Research

Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

Total article views		HTML views	PDF downloads	Totals
9,034	Dovepress*	8,481+	885	9,366
	PubMed Central*	553	235	788
	Totals	9,034	1,120	10,154
*Since 17 November 2016

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
2	0	0	0	1	1